Related Experiment Video
Updated: May 12, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Control of autophagic cell death by caspase-10 in multiple myeloma
Laurence Lamy1, Vu N Ngo, N C Tolga Emre
1Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA.
Abstract:
We performed a loss-of-function RNA interference screen to define therapeutic targets in multiple myeloma, a genetically diverse plasma cell malignancy. Unexpectedly, we discovered that all myeloma lines require caspase-10 for survival irrespective of their genetic abnormalities. The transcription factor IRF4 induces both caspase-10 and its associated protein cFLIPL in myeloma, generating a protease that does not induce apoptosis but rather blocks an autophagy-dependent cell death pathway. Caspase-10 inhibits autophagy by cleaving the BCL2-interacting protein BCLAF1, itself a strong inducer of autophagy that acts by displacing beclin-1 from BCL2. While myeloma cells require a basal level of autophagy for survival, caspase-10 tempers this response to avoid cell death. Drugs that disrupt this vital balance may have therapeutic potential in myeloma.
Insights
Multiple myeloma cells depend on caspase-10 for survival, which blocks a cell death pathway. Targeting this mechanism may offer new therapeutic strategies for this plasma cell malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Pathways
Background:
- Multiple myeloma is a genetically diverse plasma cell malignancy.
- Identifying novel therapeutic targets is crucial for effective treatment.
Purpose of the Study:
- To identify essential genes for multiple myeloma cell survival using a loss-of-function RNA interference screen.
- To elucidate the role of caspase-10 in multiple myeloma pathogenesis.
Main Methods:
- Conducted a genome-wide loss-of-function RNA interference screen in multiple myeloma cell lines.
- Investigated the regulatory network involving IRF4, caspase-10, cFLIPL, BCLAF1, and autophagy.
Main Results:
- All tested multiple myeloma cell lines require caspase-10 for survival, regardless of genetic background.
- The transcription factor IRF4 induces caspase-10 and cFLIPL, forming a protease that inhibits autophagy-dependent cell death.
- Caspase-10 cleaves BCLAF1, a key inducer of autophagy, thereby tempering the cell's survival response.
Conclusions:
- Caspase-10 plays a critical, non-apoptotic role in multiple myeloma survival by regulating autophagy.
- Disrupting the caspase-10-mediated inhibition of autophagy presents a potential therapeutic strategy for multiple myeloma.
More Related Videos
05:29Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
10:45Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization
Published on: January 13, 2012
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Intrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...